RVL Pharmaceuticals PLC
(FRA:O1P)
€
0.003
0 (0%)
Market Cap: 1.65 Mil
Enterprise Value: 38.48 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 0/100 Osmotica Pharmaceuticals PLC at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 09, 2021 / 02:45PM GMT
Release Date Price:
€2.94
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
Good morning, everyone. My name is Balaji Prasad, and I lead the specialty pharma coverage for Barclays. Thank you for dialing into the Barclays Global Healthcare Conference, still in a virtual format.
We have with us today the management team from Osmotica, Brian Markison and Andy Einhorn. So I -- the format will be a presentation from the team.
And Brian and Andy, I'll let you guys take over. Thank you.
Brian and Andy, I think you're on mute.
Brian A. Markison
Osmotica Pharmaceuticals plc - Chairman, President & CEO
Here we go. All right. How are you? Good?
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
I'm good. Yes.
Brian A. Markison
Osmotica Pharmaceuticals plc - Chairman, President & CEO
Very good. All right. Good morning, and good afternoon, everybody. This is Brian Markison. And with me today is Andrew Einhorn, our CFO; and JD Schaub, Chief
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot